Durolane 60 MG/3 ML syringe 3ML
Ended Awarded
- Contract number
- SPE2DB25FDK67
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,120
Award facts
- Contract value 100% obligated
- $17,120.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, valued at $17,120.00, was awarded on July 22, 2025, to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order covers the supply of Durolane 60 mg/3 ml syringes, a hyaluronic acid-based joint injection used for osteoarthritis treatment. The Defense Logistics Agency, which funds this delivery order, issued this firm fixed-price contract with an ultimate completion date of August 12, 2025. This award was issued without a set-aside designation, allowing DMS Pharmaceutical Group to compete on an unrestricted basis.
This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a single-award IDC valued at $499,999,999 and valid through November 2026. The IDC enables the Defense Logistics Agency to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items supporting medical supply needs across military health facilities worldwide. DMS Pharmaceutical Group has established itself as a critical supplier within the federal pharmaceutical supply chain, consistently securing contracts for diverse pharmaceutical products ranging from prescription medications to specialty treatments and medical consumables distributed to Department of Defense healthcare sites.
Quick answers
Who was awarded contract SPE2DB25FDK67?
SPE2DB25FDK67 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on July 22, 2025.
How much is contract SPE2DB25FDK67 worth?
The government has obligated $17,120 on SPE2DB25FDK67.
Is contract SPE2DB25FDK67 an order under another contract?
Yes. SPE2DB25FDK67 is a delivery order under SPE2DB22D9239, an indefinite delivery contract.
Was contract SPE2DB25FDK67 competed?
The extent of competition for SPE2DB25FDK67 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award